You are here
Professor Fergus Cameron
Professor Fergus Cameron is a Group Leader at Murdoch Childrens, Head of Diabetes Services and Deputy Director of the department of Endocrinology and Diabetes at The Royal Children's Hospital Melbourne. He has published widely in medical and lay literature about endocrine and diabetes management. Professor Cameron is a current president of the Australasian Paediatric Endocrine Group and is a participant in the Hvidoere Study Group on Childhood Diabetes. He is a past council member of the International Society for Paediatric and Adolescent Diabetes.
2006: Best Poster Award. (International Society for Pediatric and Adolescent Diabetes, Cambridge, 6-9 September, 2006. (Pediatr Diab 2006: 6(Suppl 5): 20).
2007: Citation of Merit, “GYST- a life guide for young people on the move". BioCommunications Association, Tucson, Arizona, 22-27 July, 2007.
2007: FREDDIE Award, “GYST- a life guide for young people on the move". The International Health and Media Awards, Philadelphia, 1-2 November, 2007.
2008: Best Poster Award. International Society for Pediatric and Adolescent Diabetes, Durban, 13-16 August, 2008. (Pediatr Diab 2008: 9(Suppl 10).
2008: Best Oral Presentation Award. International Society for Pediatric and Adolescent Diabetes, Durban, 13-16 August, 2008. (Pediatr Diab 2008: 9(Suppl 10).
2010: United States of America, Health Sciences Communication Award for the DVD 'WWYCD (Wicked) - Your Get-Up-and-Go Guide to Living with Type 1 Diabetes." (HeSCA Awards, Boston, June 2010)
2010: Service Medal, Equestrian Victoria (for 20 years of voluntary medical cover to equestrian sports in Victoria).
2011: Bruce Hunt Oration Speaker, University of Western Australia, Perth July 12, 2011.
2011: 20 Year Service Medal, Royal Children's Hospital, Melbourne.
2012: Best Oral Presentation Award. International Society for Pediatric and Adolescent Diabetes, Istanbul 10-13 October, 2012. (Pediatr Diab 2012: 13(Suppl 17).
Professor Cameron's particular interests are the impacts of type 1 diabetes on the development of the central nervous system and psychosocial aspects of care. His focus is to investigate better management of type 1 diabetes by testing new technology, novel drugs to reduce cardiovascular and renal disease associated with type 1 diabetes and exploring the impact of hypoglycaemia and hyperglycaemia on brain function.
- A randomised controlled trial comparing the impact of continuous subcutaneous insulin infusion therapy and multiple daily injection regimes upon indices of behaviour, cognition and glycaemia in children and adolescents with type 1 diabetes
- Predictive Low-Glucose Suspend Study: Stage 1 (In-Clinic Studies)
- The Impact of hypoglycaemia and hyperglycaemia on brain function
- Adolescent type 1 diabetes cardio-renal intervention trial (AdDIT)
- Hypoglycaemia Prevention with Predictive Suspension of Insulin Delivery (Randomised Control Trial)
Cameron FJ, Scratch SE, Nadebaum C, Northam EA, Koves I, Jennings J, Finney K, Neil JJ, Wellard RM,Mackay M, Inder TE on behalf of the DKA Brain Injury Study Group. Neurological consequences of diabetic ketoacidosis at initial presentation of type 1 diabetes in a prospective cohort of children. Diabetes Care 2014; 37:1554-62.
Russo V, Higgins S, Werther GA, Cameron FJ. Effects of fluctuating glucose levels on neuronal cells in vitro. Neurochem Res 2012; 37:1768-82.
Pell GS, Lin A, Wellard RM, Werther GA, Cameron FJ, Finch SJ, Papoutsis J, Northam EA. Age-related loss of brain volume and T2 relaxation time in youth with type 1 diabetes. Diabetes Care 2012; 35:513-9.
Koves I, Russo VC, Higgins S, Pitt J, Cameron FJ, Werther GA. An in vitro paradigm for diabetic cerebral oedema and its therapy – a critical role for taurine and water channels. Neurochem Res 2012; 37:182-92.
Northam EA, Lin A, Finch SJ, Werther GA, Cameron FJ. Psychosocial well-being and functional outcomes in youth with type 1 diabetes 12 years after disease onset. Diabetes Care 2010; 33:1430-1437.
O'Connell MA, Donath S, O'Neal DN, Colman PG, Ambler GR, Jones TW, Davis EA, Cameron FJ. Glycaemic impact of patient-led use of sensor-guided pump therapy in type 1 diabetes: a randomized control trial. Diabetologia 2009; 52:1250-7.
Malalasekera V, Cameron FJ, Grixti E, Thomas M. Potential nephro-protective effects of a gluten free diet in type 1 diabetes. Diabetologia 2009; 52:798-800.
Northam EA, Rankins D, Lin A, Wellard RM, Pell G, Finch SJ, Werther GA, Cameron FJ. Central nervous system function in youth with type 1 diabetes 12 years after disease onset. Diabetes Care 2009; 32:445-50.
O'Connell MA, Gilbertson HR, Donath SM, Cameron FJ. Optimizing glycemic control in pediatric patients with type 1 diabetes using insulin pump therapy – impact of glycemic index/load and bolus wave type on postprandial glycemia. Diabetes Care 2008; 31:1491-5.
Buckingham B, Lecher T, Hanas R, Kaiserman K, Cameron F, Wilson DM. Duration of Nocturnal Hypoglycemia and Serious Events Nocturnal Hypoglycemia and Seizures Diabetes Care 2008; 31:2110-2.